From Australian benchtop science to the largest-ever biotech IPO on the ASX, hear the story of how Dr Alan Taylor steered Clarity Pharmaceuticals to become a global leader in radiopharmaceuticals.

Ever wonder how a small Australian startup goes from benchtop science to a billion-dollar powerhouse? The answer lies in the inspiring story of Dr Alan Taylor and the team at Clarity Pharmaceuticals, who have been a Cicada resident for the past 10 years. We've had a front-row seat to their incredible journey, witnessing Alan grow the team and business from two provisional patents and no full-time employees to a global leader in radiopharmaceuticals within our four walls.

Three years ago, Clarity achieved the largest-ever life sciences listing on the ASX. We're excited to sit down with Dr. Alan Taylor, Executive Chairman, to uncover the secrets behind this remarkable achievement.

Dr. Taylor will share Clarity's success story in an exclusive fireside chat led by Dr Katja Beitat, Cicada's Head of Health Tech, covering:

- From Lab to Market: The challenges and triumphs of taking a scientific concept and building a successful company.
- Unlocking Growth: Discover how Clarity leveraged its resources to secure over $250 million in funding and achieve the largest-ever life sciences listing on the ASX.
- Building a Billion-Dollar Vision: Discover Dr. Taylor's unique leadership strategies honed through a diverse background in medicine, research, and investment banking. With over 15 years in investment banking, advising numerous healthcare, life sciences, and technology companies, and executing capital raisings and mergers & acquisitions worth approximately $2 billion, Dr. Taylor brings a wealth of experience.

This event will be hosted at the Innovation Quarter Building at Westmead and will also be an opportunity to tour the recently inaugurated Cicada HealthTech Hub facilities.

Join us for this momentous occasion in Australian innovation as we unfold one of the most powerful stories in Australian science.